Huron Consulting Group Inc. (HURN) At $36.90 Forms Top; Citius Pharmaceuticals (CTXR) Shorts Up By 106.25%

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Logo

Huron Consulting Group Inc. (HURN) formed multiple top with $39.11 target or 6.00% above today’s $36.90 share price. Huron Consulting Group Inc. (HURN) has $793.00 million valuation. The stock increased 1.23% or $0.45 during the last trading session, reaching $36.9. About 83,852 shares traded. Huron Consulting Group Inc. (NASDAQ:HURN) has declined 12.86% since May 13, 2017 and is downtrending. It has underperformed by 24.41% the S&P500.

Citius Pharmaceuticals Inc (NASDAQ:CTXR) had an increase of 106.25% in short interest. CTXR’s SI was 16,500 shares in May as released by FINRA. Its up 106.25% from 8,000 shares previously. With 29,300 avg volume, 1 days are for Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s short sellers to cover CTXR’s short positions. The SI to Citius Pharmaceuticals Inc’s float is 0.64%. It closed at $2.64 lastly. It is down 54.81% since May 13, 2017 and is downtrending. It has underperformed by 66.36% the S&P500.

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapeutic products. The company has market cap of $28.16 million. The firm develops Mino-Lok product, which has completed Phase IIb clinical trials for the treatment of catheter related bloodstream infections; and Hydrocortisone-Lidocaine Cream for the treatment of mild to moderate hemorrhoids. It currently has negative earnings. It has a collaboration and license agreement with Alpex Pharma S.A. to develop and commercialize orally disintegrating tablet formulations of pharmaceutical products in United States, Canada, and Mexico.

Among 5 analysts covering Huron Consulting Group (NASDAQ:HURN), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Huron Consulting Group had 13 analyst reports since July 30, 2015 according to SRatingsIntel. Barrington Research downgraded the shares of HURN in report on Tuesday, February 21 to “Mkt Perform” rating. On Wednesday, October 18 the stock rating was maintained by SunTrust with “Buy”. The company was downgraded on Tuesday, January 3 by William Blair. The rating was maintained by Deutsche Bank with “Buy” on Thursday, September 17. The rating was maintained by Barrington Research on Monday, October 26 with “Outperform”. The stock of Huron Consulting Group Inc. (NASDAQ:HURN) has “Buy” rating given on Monday, September 21 by William Blair. William Blair upgraded the stock to “Outperform” rating in Friday, September 8 report.

Investors sentiment decreased to 0.84 in 2017 Q4. Its down 0.26, from 1.1 in 2017Q3. It worsened, as 17 investors sold Huron Consulting Group Inc. shares while 39 reduced holdings. 22 funds opened positions while 25 raised stakes. 20.25 million shares or 2.32% more from 19.79 million shares in 2017Q3 were reported. 41,907 are held by Susquehanna Int Grp Incorporated Llp. Atlanta Capital Mngmt L L C holds 516,245 shares. Tower Cap Limited Liability Corporation (Trc) has 0.02% invested in Huron Consulting Group Inc. (NASDAQ:HURN) for 3,768 shares. Tiaa Cref Investment Ltd Liability Corporation accumulated 74,836 shares or 0% of the stock. 464 were accumulated by Parkside Bancshares. 34,160 are held by Alliancebernstein L P. Pnc Financial Group Incorporated Inc has invested 0% in Huron Consulting Group Inc. (NASDAQ:HURN). Bnp Paribas Arbitrage Sa holds 0% of its portfolio in Huron Consulting Group Inc. (NASDAQ:HURN) for 6,885 shares. Asset One holds 0% of its portfolio in Huron Consulting Group Inc. (NASDAQ:HURN) for 3,540 shares. 240,761 are owned by Jennison Assoc Limited Com. Public Employees Retirement Sys Of Ohio stated it has 0.01% of its portfolio in Huron Consulting Group Inc. (NASDAQ:HURN). Rhumbline Advisers holds 24,688 shares. 486,850 were reported by State Street Corporation. The California-based Wells Fargo And Mn has invested 0% in Huron Consulting Group Inc. (NASDAQ:HURN). Ameriprise stated it has 37,941 shares or 0% of all its holdings.

Huron Consulting Group Inc. (NASDAQ:HURN) Institutional Positions Chart